This session explores perspectives on advancing cardio-kidney-metabolic care. Distinguished experts discuss advances in reducing residual cardiovascular risk by anti-inflammatory agents, and examine the rationale for establishing comprehensive cardio-metabolic-renal care models. Together, the presentations highlight evolving concepts that can reshape clinical practice across multidisciplinary fields.